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ORTHOTOPIC LIVER TRANSPLANTATION IN THE MOUSE 
Heart and kidney transplantation in the mouse has been well 
established (1,2), but orthotopic liver transplantation has not 
been reported. Although the mouse is one-tenth the size of the 
rat, there are many advantages to using the mouse for immu-
nologic research. The mouse genome has been more thoroughly 
characterized than the rat or any other species of mammal. 
The mouse H-2 system also bears a striking resemblance to the 
human HLA system. In addition, there are numerous geneti-
cally defined inbred strains and wealth of monoclonal antibod-
ies that are commercially available for mouse investigations. 
A key development in rat orthotopic liver transplantation 
(3) was the introduction by Zimmerman et al. (4) and Kamada 
and Caine (5), of the cuff technique instead of suture for some 
of the venous vascular anastomoses. This method shortened 
the clamping time of the portal vein and increased survival. 
We have applied this principle to mouse orthotopic liver trans-
plantation. In our pilot studies, more than 40 syngeneic mouse 
liver replacements were performed before 6 long-term survivors 
were obtained. The experience reported here is with the next 
48 attempts, in which the surgical success rate was 83%. 
Male inbred syngeneic mice 10-12 weeks old (25-32 g), from 
Jackson Laboratory, Bar Harbor, ME, were used as size-
matched donors and recipients under methoxyflurane (2.2-
dichloro-1,1-difluoroethyl methyl ether) anesthesia. The 
strains used were B6AF1 (27 pairs), C57BL/6 (11 pairs). and 
BALB/c (10 pairs). Clean but not sterile operative technique 
was used, and all procedures were performed under the oper-
ating microscope with 4-6.4x magnification. 
Donor operation. After shaving and disinfecting the abdomen 
with Betadine or alcohol, a complete midline incision was made. 
Four small retractors and a retracting clamp on the xiphoid 
process provided exposure. The bile duct was transected. The 
pyloric, splenic, right adrenal, and right renal veins, as well as 
the hepatic artery were ligated. Heparin (100 units) diluted to 
0.3 ml with lactated Ringer's solution was slowly injected into 
the penile vein. After cross-clamping the thoracic aorta and 
dividing the suprahepatic vena cava close to the diaphragm, 
the liver was perfused with 1 ml cold lactated Ringer's solution, 
given through the abdominal aorta. Since the hepatic artery 
was already ligated, the liver perfusion was from the splanchnic 
venous return. The liver and surrounding tissues were kept cool 
with frequent rinses of cold lactated Ringer's solution. The 
infrahepatic vena cava was divided at the level of the left renal 
vein, leaving a sufficient length for cuff preparation. The freed 
liver was then placed into a container of cold lactated Ringer's 
solution for further preparation. The cystic duct was ligated 
and the gallbladder removed. The infrahepatic vena cava and 
the portal vein were cleaned for insertion through Teflon tubes 
(outer diameter 1.7 mm for vena cava, 1.2 mm for portal vein), 
using a cuff length of 1.5 mm and an equal vein length, which 
was folded back and tied (Fig. 1). These steps were facilitated 
by a stabilizing clamp. 
Recipient operation. Through a midline incision. the bile duct, 
hepatic artery, and right adenal vein were ligated and divided. 
The liver ligaments were incised and the suprahepatic vena 
cava was encircled with a ligature, which was used to pull the 
liver and diaphragm down for application ota Santinsky clamp 
on the suprahepatic vena cava. When the liver was removed, 
the infrahepatic vena cava, portal vein, and suprahepatic vena 
cava were cross-clamped, in that order. Maximum length was 
retained with the recipient to facilitate the venous reconnec-
tions. The suprahepatic vena cava anastomosis was constructed 
first with a continous 10-0 nylon suture (Dermalon, Davis & 
Geck Inc.). A one-suture anastomosis technique was used to 
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FIGURE 1. Method of venous cuff preparation used for the portal 
vein and infrahepatic vena cava. Note that the liver is submerged in 
cold solution during these maneuvers. 
FIGURE 2. Continuous suture anastomosis of the suprahepatic vena 
cava, using a one-suture technique for manipulation and exposure of 
the posterior vessel walls. 
aid in manipulating and visualizing the posterior anastomotic 
wall (Fig. 2). Next, the graft portal vein cuff was inserted into 
a venotomy in the anterior wall of the recipient portal vein 
which was kept on tension with a clamp and inflated with 
injected saline. A silk tie was placed to secure the vein over the 
cuff and the liver was revascularized by removing the supra-
hepatic and portal venous clamps. Portal venous occlusion was 
always for less than 20 min. The infrahepatic vena cava cuff 
was inserted in a ;·similar way, taking care to avoid excessive 
retrograde bleeding in the process. No attempt at rearteriali-
zation was made. Biliary continuity was restored by tying the 
ducts over a 4-mm polyethylene tube stent (00 of 0.61 mm, 
Becton Dickinson; Parsippany, NJ). Blood lost during opera-
tion was replaced with lactated Ringer's solution. The abdomen 
was closed in two layers. Single intramuscular injections of 5 
mg cefamandol nafate and 60,000 units Bicillin were given and 
the mice were kept under a warming lamp until they became 
active. Food and water were allowed ad libitum. 
Eight mice were bled from the retroorbital sinus weekly for 
the first month and monthly thereafter postoperatively for 
determination of serum glutamic oxaloacetic transaminase"al-
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FIGURE 3. Life survival (actual) after syngeneic liver replacement 
in three strains of mice. 
kaline phosphatase, bilirubin, total protein, and albumin. Ani-
mals that died from complications of the operation were autop-
sied, and histopathologic analyses were obtained when the 
cause of death was not readily apparent. In long-term survivors, 
tissues for histopathology were obtained by reoperation and 
wedge biopsy. Tissues were fixed in neutral buffered formalin, 
embedded in paraffin, sectioned at 4 p. and stained with he-
matoxylin and eosin. 
Of the 48 recipients, 40 (83.3%) lived for more than one 
week, and 27 (67%) lived more than 100 days. The longest 
survivors have been followed for more than 12 months. The 
survival curves were similar in the 3 strains (Fig. 3). 
The deaths in the first postoperative week were from tech-
nical causes. The causes of death of the 13 recipients that died 
between 8 and 100 days were bile duct complications (4 exam-
ples), peritonitis (3), pneumonia (3), phlebotomy for blood 
sample collection (2), and unknown (1). The delayed deaths 
were concentrated in the second and third weeks (Fig. 3), and 
after this only a single mouse was lost (from a phlebotomy). 
Because 2 mice died from the phlebotomies, one early and 
one late, only 6 provided enough serial samples to be included. 
The SGOT levels were elevated after transplantation, as were 
the serum bilirubins, but these returned to or toward normal 
except in an animal that died of bile duct complications. In 
contrast to the other biochemical tests, the alkaline phospha-
tases tended to become worse with time and were above the 
upper limits of normal in all animals tested for the full 100 
days. Total protein and albumin levels were normal except in 
the animals that died of bile duct complications. 
Histopathologic studies showed that mice that died within 3 
weeks had areas of scattered coagulation necrosis, most prom-
inently in the hepatic hilum. Abscesses of variable sizes were 
in or around the infarcted areas. Mononuclear infiltrates were 
not seen in the viable liver but the liver sinusoids frequently 
contained neutrophils. The extrahepatic organs were unre-
markable. 
Two mice had open liver biopsy at 49 and 56 days, and a 
third was killed at 133 days. Grossly, the livers appeared 
normal. Histopathologically, the livers had no major changes 
(Fig. 4), although there were subtle, usually focal, abnormali-
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FIGURE 4. Syngeneic liver graft of mouse killed 133 days postoper-
atively (H&E; original magnification: X40). 
ties. Many of the triads had mild fibrosis and/or mild ductular 
proliferation with a light lymphoplasmocytic inflammatory in-
filtrate. The duct epithelium frequently showed apoptosis and 
vacuolization. Hepatic arteries were difficult or impossible to 
identify in most of the triads. There was no evidence of choles-
tasis. 
To our knowledge, this is the first description of orthotopic 
liver transplantation in the mouse. Although the surgical prin-
ciples and techniques of OLT in the mouse are similar to those 
in the rat, the procedure is more difficult because of the smaller 
size. The most troublesome step was the suprahepatic vena 
cava anastomosis. This was facilitated by using one-suture 
anastomosis technique for the purpose of manipulation and 
ensurance of lumen patency. The anastomosis, which required 
12-16 min, was performed with continuous 10-0 Dermalon 
because of the softness and flexibility of this suture. In our 
developmental series, and in a few of the animals in the 
definitive series, an anhepatic period greater than 20 min was 
incompatible with consistent success. This may reflect an in-
tolerance of the mouse to hepatic ischemia, to venous conges-
tion of the splanchnic and systemic systems, or to both. In the 
rat, an anhepatic period less than 26 min can be routinely 
tolerated (5). 
The lethal surgical complications were from defective revas-
cularization of the portal vein. As with the rat (4, 5), failure to 
provide an arterial blood supply did not jeopardize long survival. 
However, degenerative changes in the biliary epithelium and 
other subtle histopathologic abnormalities in the portal triads 
may have been the consequence of this omission. It is notewor-
thy that the canalicular enzyme, alkaline phosphatase, was the 
one biochemical index that did not become normal during the 
100-day period of observation. 
Notwithstanding this potential imperfection, the mouse 
model should be useful in the future study of liver transplan-
tation. Since numerous genetically defined inbred strains-
including congenic strains of mice-are available, immunologic 
studies should be possible with greater precision than has been 
feasible until now. The resulting new information obtained may 
help to explain why the liver is privileged relative to other 
organs and why it may have a protective effect on other 
concomitantly transplanted organs (5). The availability of well-
defined monoclonal antibody reagents will allow tracer studies 
and identification of cells involved in allorecognition and rejec-
tion or the tolerance induction which is incongruously easy 
after liver transplantation (6). The prospect of evaluating 
monoclonal antibodies for therapeutic purposes is equally in-
viting. Finally, several unique liver disease models, such as 
mouse viral hepatitis, that are analogs of human disorders, can 
be studied in greater detail (7, 8). 
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